Skip to main content
Top

Breast Cancer Research and Treatment

Issue 3/2006

Content (14 Articles)

Analysis of angiogenesis genes from paraffin-embedded breast tumor and lymph nodes

Bryan P. Schneider, Todd C. Skaar, George W. Sledge, Sunil Badve, Lang Li, David A. Flockhart

Report

Characterization of an in vitro cell culture bioreactor system to evaluate anti-neoplastic drug regimens

Mark N. Kirstein, Richard C. Brundage, William F. Elmquist, Rory P. Remmel, Paul H. Marker, Dan E. Guire, Douglas Yee

Epidemiology

Diet quality is directly associated with quality of life in breast cancer survivors

Sharon J Wayne, Kathy Baumgartner, Richard N Baumgartner, Leslie Bernstein, Deborah J Bowen, Rachel Ballard-Barbash

Preclinical study

Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce “danger signals”

Masoud H. Manjili, Hilal Arnouk, Keith L. Knutson, Maciej Kmieciak, Mary L. Disis, John R. Subjeck, A. Latif Kazim

Erratum

Erratum to: Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce “danger signals”

Masoud H. Manjili, Hilal Arnouk, Keith L. Knutson, Maciej Kmieciak, Mary L. Disis, John R. Subjeck, A. Latif Kazim

Clinical trial

Treatment-induced menstrual changes in very young (<35 years old) breast cancer patients

Whoon Jong Kil, Seung Do Ahn, Seong Soo Shin, Sang-wook Lee, Eun Kyung Choi, Jong Hoon Kim, Byung Ho Son, Sei-Hyun Ahn, Woo Kun Kim, Sung Bae Kim

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose–dense sequential adjuvant chemotherapy

Ioannis Kostopoulos, Petroula Arapantoni-Dadioti, Helen Gogas, Savvas Papadopoulos, Vasiliki Malamou-Mitsi, Chrisoula D. Scopa, Sofia Markaki, Evangelia Karagianni, Vasiliki Kyriakou, Anastasia Margariti, Elisavet Kyrkou, Kitty Pavlakis, Thomas Zaramboukas, Anna Skordalaki, Antonia Bourli, Christos Markopoulos, Dimitrios Pectasides, Meletios A. Dimopoulos, Dimosthenis Skarlos, George Fountzilas

Epidemiology

Breast cancer and long-term hormonal treatment of male hypogonadism

Marek Medras, Filus Alicja, Jozkow Pawel, Winowski Jacek, Sicinska Werner Teresa

Preclinical study

Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo

Yingchao Zhang, Yu Wang, Wenxin Gao, Ruhui Zhang, Xichun Han, Mingku Jia, Wenzeng Guan

Epidemiology

Effect of model of care delivery on mammography use among elderly breast cancer survivors

Ann Eka-Ete P. Etim, Kenneth G. Schellhase, Rodney Sparapani, Ann B. Nattinger

Letter to the Editor

Overcoming trastuzumab resistance with nordihydroguaiaretic acid?

Kadri Altundag, Ozden Altundag, Ebru Karakaya, Serap Akyurek

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine